Back to NORTHERN TRUST CORP NORTHERN TRUST CORP

MRKRMRKR
Showing 8 of 14 quarters

Position history for NORTHERN TRUST CORPNORTHERN TRUST CORP's holdings in MARKER THERAPEUTICS INC

NORTHERN TRUST CORP holds 34,629 shares of MRKR (MARKER THERAPEUTICS INC), worth $50,905 as of 2026-Q2. The position was increased (+33.1% shares).

Current Value

$50,905

Current Shares

34,629

Total Value Change

-$40,612

Total Shares Change

+2,176

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
34,629
+33.1%
$50,9050.0%$1.47
18
2026-Q1
Unchanged
26,009
0.0%
$33,8120.0%$1.37
0
2025-Q4
Increased
26,009
+139.6%
$38,7530.0%$1.47
22
2025-Q3
Unchanged
10,857
0.0%
$9,6910.0%$0.93
0
2025-Q2
Unchanged
10,857
0.0%
$16,6110.0%$1.46
0
2025-Q1
Decreased
10,857
-80.0%
$13,3540.0%$1.27
0
2024-Q4
Increased
54,156
+66.9%
$168,4250.0%$3.34
23
2024-Q3
Decreased
32,453
-2.8%
$91,5170.0%$2.90
0

Other major holders of MRKR: Alyeska Investment Group, L.P., Hudson Bay Capital Management LP, VANGUARD GROUP INC, VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used